Evaluation of safety and tolerability of durvalumab (D) with or without tremelimumab (T) in patients (pts) with biliary tract cancer (BTC).

医学 耐受性 队列 胆道癌 内科学 不利影响 胃肠病学 加药 癌症 外科 吉西他滨
作者
Tatsuya Ioka,Makoto Ueno,Do‐Youn Oh,Yutaka Fujiwara,Jen‐Shi Chen,Yuichiro� Doki,Nobumasa Mizuno,Keunchil Park,Akinori Asagi,Manabu Hayama,Masahiro Nii,Keiko Komuro,Mariko Sugimoto,Gordana Vlahovic,Masafumi Ikeda
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:37 (4_suppl): 387-387 被引量:104
标识
DOI:10.1200/jco.2019.37.4_suppl.387
摘要

387 Background: This Phase 1 study (NCT01938612) evaluated D (anti-PD-L1 mAb) and T (anti-CTLA-4 mAb) in Asian pts, in whom optimal dosing of D and T is undetermined. No dose-limiting toxicities were observed, and durable responses were seen in a dose escalation phase evaluating various D doses and regimens in Japanese pts (Iguchi, ASCO 2015). The study was subsequently expanded to larger cohorts of Asian pts with advanced solid tumors including BTC. Methods: Two regimens were selected for the expansion phase: D monotherapy (10 mg/kg q2w) and D+T (D 20 mg/kg + T 1.0 mg/kg q4w). One cohort of pts with advanced BTC was enrolled to receive D monotherapy followed by a separate cohort that received D+T with additional pts enrolled if efficacy was observed. Safety, response, and survival endpoints were based on investigator assessment. Results: Pts were enrolled to D (N = 42) or D+T (N = 65). Median age was 64 years for the D cohort and 62 years for the D+T cohort, the majority were male, and ECOG PS was 0 or 1: 64% and 36% for pts in the D cohort and 49% and 51% for pts in the D+T cohort, respectively. Median number of prior chemotherapy regimens was 2 for both cohorts. Treatment-related adverse events (trAE) of any grade occurred in 64% and 82% of pts in the D and D+T cohorts. Grade ≥ 3 trAEs occurred in 19% and 23% of pts in the D and D+T cohorts. trAEs led to discontinuation in 2 pts in the D cohort and 5 pts in the D+T cohort. A death due to trAE (drug-induced liver injury) was reported in the D+T cohort, none in the D cohort. In the D cohort, 2 pts had a partial response (PR) and 7 pts had a PR in the D+T cohort; disease control rate at 12 weeks was 16.7% and 32.2%, respectively. Median duration of response for the D cohort was 9.7 months and 8.5 months for the D+T cohort. Median overall survival was 8.1 (95% CI, 5.6-10.1) months and 10.1 (95% CI, 6.2-11.4) months for the D and D+T cohorts, respectively. Conclusions: Both D monotherapy and D+T combination therapy were tolerable for Asian pts with BTC, and no unexpected toxicities were observed with either regimen. Promising clinical benefit was observed with both D and D+T therapy. This study provides valuable information regarding these therapeutic regimens for future studies in pts with BTC. Clinical trial information: NCT01938612.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
在水一方应助lm采纳,获得10
刚刚
1秒前
Ava应助oui采纳,获得10
1秒前
能干的吐司完成签到,获得积分10
2秒前
2秒前
jjjdcjcj发布了新的文献求助10
2秒前
周破儿完成签到,获得积分10
2秒前
量子星尘发布了新的文献求助10
2秒前
传奇3应助明朗采纳,获得10
3秒前
3秒前
3秒前
4秒前
senhoo发布了新的文献求助10
4秒前
4秒前
小狗完成签到 ,获得积分10
5秒前
6秒前
6秒前
昏睡的实验室小白完成签到,获得积分10
7秒前
7秒前
yar应助大青山采纳,获得10
7秒前
Rondab应助mariawang采纳,获得10
7秒前
yqb发布了新的文献求助10
7秒前
7秒前
一条裸游的鱼完成签到,获得积分10
9秒前
二白关注了科研通微信公众号
9秒前
10秒前
10秒前
超帅听枫发布了新的文献求助10
10秒前
12秒前
12秒前
fish1116发布了新的文献求助100
12秒前
12秒前
bbbbb沫完成签到,获得积分20
12秒前
峥2发布了新的文献求助10
12秒前
wzy完成签到,获得积分10
12秒前
xxxllllll发布了新的文献求助10
13秒前
干净映天完成签到 ,获得积分10
13秒前
LJ_scholar发布了新的文献求助10
14秒前
kuny完成签到,获得积分10
14秒前
勤恳的夏之完成签到,获得积分20
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988732
求助须知:如何正确求助?哪些是违规求助? 3531027
关于积分的说明 11252281
捐赠科研通 3269732
什么是DOI,文献DOI怎么找? 1804764
邀请新用户注册赠送积分活动 881869
科研通“疑难数据库(出版商)”最低求助积分说明 809021